The phrase "are capable of advancing" is correct and usable in written English.
It can be used to describe someone's or something's ability to make progress or improve in a particular area.
Example: "The new training program ensures that employees are capable of advancing their skills and knowledge."
Alternatives: "have the ability to progress" or "are able to improve".
"I push for harmony, but only if we are capable of advancing that way.
These data suggest that the 3′ URA3 sequences are capable of advancing origin activation time.
The forkhead transcription factors, Fkh1 and Fkh2, are capable of advancing origin activation time over a distance of at least 500 bp (Knott et al. 2012).
By combining deletion and linker scanning mutational analysis with two-dimensional gel electrophoresis to measure fork direction in the context of a two-origin plasmid, we have identified and characterized a 19- to 23-bp and a larger 584-bp DNA sequence that are capable of advancing origin activation time.
Indeed, I go so far as to say that in the vast majority of cases, in magistrates' courts anyway, defendants would like their identity to be unrevealed and would be capable of advancing seemingly plausible reasons why that should be so.
While Weber shares some of Marx's consternation with bureaucratic systems and maligns them as being capable of advancing their own logic to the detriment of human freedom and autonomy, Weber views conflict as perpetual and inevitable and does not host the spirit of a materially available utopia.
Hydrogen peroxide has not previously been directly implicated in these processes, however it is interesting to note that exogenous hydrogen peroxide has been shown to be capable of advancing the period of the yeast metabolic cycle [10].
Because RpoS also has a small effect on LasR and RhlR expression [ 15], it appears that RpoS is capable of advancing many genes only indirectly through LasR and RhlR.
The failure to engage hypothesis [ 7] states that people are capable of advance preparation when a switch between two tasks has to be made, but fail to do so on a subset of trials.
When we interviewed the management of the various research institutions, they cited deficiency in scientific infrastructure and a shortfall in the number of trained scientists who are capable of carrying out advanced health biotechnology research as one of the major challenges.
"We are capable of dealing with very technologically advanced competition globally and doing so in a world beating manner".
